Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)
| 0.20 Data as of May 24 |  -0.0005 / -0.25%Today’s Change | 0.18 Today|||52-Week Range 1.10 | -20.26% Year-to-Date |
Latest HEB News | Press Releases
No recent news for Hemispherx Biopharma Inc.
Today’s Trading
| Previous close | 0.20 |
| Today’s open | 0.20 |
| Day’s range | 0.20 - 0.21 |
| Volume | 589,518 |
| Average volume (3 months) | 530,010 |
| Market cap | $33.4M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -71.43% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | +32.30% |
| P/E ratio | NM |
| Price/Sales | 166.04 |
| Price/Book | 0.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MSTXMast Therapeutics In... | +0.04 | +5.80% |
| ECTEEcho Therapeutics In... | +0.03 | +5.45% |
| IDRAIdera Pharmaceutical... | -0.01 | -2.16% |
| IPCIIntellipharmaceutics... | +0.03 | +1.72% |
Data as of 3:59pm ET, 05/24/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $213.0K |
| Annual profit (last year) | -$17.4M |
| Net profit margin | -8,147.42% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President, Chief Executive Officer & CSO William A. Carter, MD |
Senior Vice President- Operations Wayne S. Springate |
Corporate headquarters Philadelphia, Pennsylvania |
Forecasts
